Your browser doesn't support javascript.
loading
The role of KCNQ channel activators in management of major depressive disorder.
Meshkat, Shakila; Kwan, Angela T H; Le, Gia Han; Wong, Sabrina; Rhee, Taeho Greg; Ho, Roger; Teopiz, Kayla M; Cao, Bing; McIntyre, Roger S.
Afiliação
  • Meshkat S; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada.
  • Kwan ATH; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada; Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Electronic address: angela.kwan@mail.utoronto.ca.
  • Le GH; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada. Electronic address: hanny.le@mail.utoronto.ca.
  • Wong S; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada. Electronic address: sabrinal.wong@mail.utoronto.ca.
  • Rhee TG; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA; Department of Public Health Sciences, Farmington, CT, USA. Electronic address: taeho.rhee@yale.edu.
  • Ho R; Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Institute for Health Innovation and Technology (iHealthtech), National University of Singapore, Singapore. Electronic address: pcmrhcm@nus.edu.sg.
  • Teopiz KM; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada. Electronic address: kayla.teopiz@mail.utoronto.ca.
  • Cao B; Key Laboratory of Cognition and Personality, Faculty of Psychology, Ministry of Education, Southwest University, Chongqing 400715, PR China. Electronic address: bingcao@swu.edu.cn.
  • McIntyre RS; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada. Electronic address: roger.mcintyre@bcdf.org.
J Affect Disord ; 359: 364-372, 2024 Aug 15.
Article em En | MEDLINE | ID: mdl-38772507

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenilenodiaminas / Carbamatos / Transtorno Depressivo Maior / Canais de Potássio KCNQ / Antidepressivos Limite: Animals / Humans Idioma: En Revista: J Affect Disord Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá País de publicação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenilenodiaminas / Carbamatos / Transtorno Depressivo Maior / Canais de Potássio KCNQ / Antidepressivos Limite: Animals / Humans Idioma: En Revista: J Affect Disord Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá País de publicação: Holanda